Profibrix B.v.

Mallinckrodt Pharma IP Trading D.a.c.

Innovata Limited

Glen Martyn

Jacob Koopman

Richard I Senderoff

Linda Zuckerman

Eliane Schutte

Nicola Kim Whitfield

Peter Crew

Fiona Dey

The present invention relates to novel formulations comprising a dry powder fibrin sealant comprised of a mixture of fibrinogen and/or thrombin, for use in the treatment of wounds or injuries, in particular for use as a topical hemostatic composition or for surgical intervention.

Formulations for wound therapy

A fibrin sealant comprises a mixture of first microparticles that comprise fibrinogen, second microparticles that comprise thrombin, and additive material. The additive material may be particulate, and may be, for instance, a biocompatible, water-absorbent, material, a biocompatible, water-swellable material, a biocompatible, water-insoluble material, a polysaccharide or silica.

Dry powder fibrin sealant

The present invention relates to a dry powder fibrin sealant which comprises a mixture of fibrinogen and thrombin for use in surgery, trauma and other wounds or injuries. It further relates to novel formulations comprising said dry powder fibrin sealant for use in the treatment of wounds or for surgical intervention or as a topical hemostat.

Growing community of inventors

Leicestershire, United Kingdom

Glen Martyn